Advisory Committees; Conversion of Ad Hoc Advisory Committee to Standing Advisory Committee

The Food and Drug Administration (FDA) is amending the standing advisory committees' regulations to add the name and function of the Transmissible Spongiform Encephalopathies Advisory Committee (formerly Ad Hoc Advisory Committee on Creutzfeldt-Jakob Disease). Appearing elsewhere in this issue of the Federal Register is a notice announcing the renewal of this advisory committee. A notice requesting nominations for membership on this committee will publish at a later date. This action is being taken to incorporate this committee into the agency's list of standing advisory committees because it will no longer be serving in an ad hoc capacity.